Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis

NCT01556503 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT01556503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01556503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
Lead sponsor
OHSU Knight Cancer Institute
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
November 30, 2013
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma